Literature DB >> 15547025

The safety and effectiveness of a nurse led cardioversion service under sedation.

L Boodhoo1, G Bordoli, A R Mitchell, G Lloyd, N Sulke, N Patel.   

Abstract

OBJECTIVE: To assess the safety and effectiveness of nurse led elective cardioversion of atrial fibrillation under sedation.
DESIGN: Prospective, longitudinal study.
SETTING: Cardiac catheterisation laboratory and recovery area of a district general hospital. PATIENTS: 300 patients referred for elective cardioversion of persistent atrial fibrillation.
INTERVENTIONS: Pre-procedure evaluations (history, physical examination, blood tests), consent, sedation administration, cardioversions, and post-procedure monitoring until discharge by advanced life support certified coronary care unit nurses trained in the techniques. A doctor was immediately available if required but not present. MAIN OUTCOME MEASURES: Success rates at discharge and at six weeks, energy delivered, number of shocks, dose of sedation, immediate, 24, and 48 hour patient perceptions, complications, waiting times, and cost effectiveness.
RESULTS: Cardioversion success rate was 87% at discharge and 48% at six weeks. Mean (SD) cumulative energy was 497 (282) J and number of shocks 1.6 (0.8). Mean (SD) dose of sedation was 23 (9) mg intravenous diazepam. No patient required reversal of sedation, airway support, or medical intervention. Ninety eight per cent of patients had no pain or recall of the procedure. Four patients who were adequately anticoagulated experienced embolic phenomena. Ninety eight per cent of patients would repeat the procedure if necessary. Without requirement for a physician or anaesthetist, waiting times for elective cardioversion fell from three months to under four weeks. There was a significant reduction in the estimated cost of the procedure from 337 pounds sterling with general anaesthesia to 130 pounds sterling with nurse led sedation and cardioversion (p < 0.001).
CONCLUSION: With appropriate training, a nurse led cardioversion service with sedation is safe, effective, well tolerated, and cost efficient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15547025      PMCID: PMC1768581          DOI: 10.1136/hrt.2004.034900

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  14 in total

1.  Sedation by physician with diazepam for DC cardioversion of atrial arrhythmias.

Authors:  P J Pugh; P Spurrell; K Kamalvand; A N Sulke
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

2.  Role of conscious sedation for external cardioversion.

Authors:  R Raipancholia; L Sentinella; M Lynch
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

3.  Physician administered sedation for DC cardioversion.

Authors:  S J Harrison; J Mayet
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

4.  Exploring the expanded role of nurses in critical care.

Authors:  M Hind; D Jackson; C Andrewes; P Fulbrook; K Galvin; S Frost
Journal:  Intensive Crit Care Nurs       Date:  1999-06       Impact factor: 3.072

5.  Diazepam in cardioversion.

Authors:  G Forssell; R Nordlander; O Nyquist; E Orinius
Journal:  Acta Med Scand       Date:  1975-04

6.  Experiences with electrical cardioversion in an outpatient clinic.

Authors:  J H Woodbridge
Journal:  J Miss State Med Assoc       Date:  1969-12

Review 7.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

8.  Clinical competence in elective direct current (DC) cardioversion. A statement for physicians from the ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology.

Authors: 
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

9.  Comparison between diazepam and sodium thiopental during DC countershock.

Authors:  J J Muenster; M S Rosenberg; R A Carleton; J S Graettinger
Journal:  JAMA       Date:  1967-03-06       Impact factor: 56.272

10.  Diazepam or midazolam for external DC cardioversion (the DORM Study).

Authors:  A R J Mitchell; S Chalil; L Boodhoo; G Bordoli; N Patel; N Sulke
Journal:  Europace       Date:  2003-10       Impact factor: 5.214

View more
  8 in total

1.  Cardioversion and the use of sedation.

Authors:  S J Harrison; J Mayet
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

Review 2.  Rhythm control and cardioversion.

Authors:  N Sulke; F Sayers; G Y H Lip
Journal:  Heart       Date:  2006-09-08       Impact factor: 5.994

3.  A dedicated cardioversion unit for the treatment of atrial fibrillation. Reducing costs by optimizing processes.

Authors:  C Knackstedt; M Becker; K Mischke; R Pauling; H P Brunner-La Rocca; P Schauerte
Journal:  Herz       Date:  2011-11-19       Impact factor: 1.443

4.  Treating the right patient at the right time: an innovative approach to the management of atrial fibrillation.

Authors:  Anne M Gillis; Laurie Burland; Beverly Arnburg; Cheryl Kmet; P Timothy Pollak; Katherine Kavanagh; George Veenhuyzen; D George Wyse
Journal:  Can J Cardiol       Date:  2008-03       Impact factor: 5.223

5.  Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models.

Authors:  Patrick M Boyle; Michael J Murphy; Thomas V Karathanos; Sohail Zahid; Robert C Blake; Natalia A Trayanova
Journal:  J Physiol       Date:  2017-12-28       Impact factor: 5.182

6.  A comprehensive multiscale framework for simulating optogenetics in the heart.

Authors:  Patrick M Boyle; John C Williams; Christina M Ambrosi; Emilia Entcheva; Natalia A Trayanova
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department.

Authors:  Giulia Stronati; Alessandro Capucci; Antonio Dello Russo; Erica Adrario; Andrea Carsetti; Michela Casella; Abele Donati; Federico Guerra
Journal:  BMC Cardiovasc Disord       Date:  2020-08-25       Impact factor: 2.298

8.  National mixed methods evaluation of the effects of removing legal barriers to full practice authority of Dutch nurse practitioners and physician assistants.

Authors:  Daisy P De Bruijn-Geraets; Yvonne J L van Eijk-Hustings; Monique C M Bessems-Beks; Brigitte A B Essers; Carmen D Dirksen; Hubertus Johannes Maria Vrijhoef
Journal:  BMJ Open       Date:  2018-06-22       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.